Printed from Voxsanity (voxsanity.com.au) — NCT07489599 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Alzheimers Disease
Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting
NCT07489599
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to take part and sign a consent form agreeing to participate.
- Men or women between 18 and 65 years old (inclusive).
- People who are in good health, confirmed by a medical check-up.
- People whose body mass index (BMI) falls between 19 and 28 kg/m² (a standard measure of body weight relative to height).
- People who agree to use effective birth control and have no plans to donate sperm or eggs, or to become pregnant, from the time of signing the consent form until 9 months after receiving the study drug.
- People who are willing to take part, sign a consent form, are able to communicate well with the research team, and can complete all parts of the trial as required.
- Men or women between 50 and 85 years old (inclusive).
- People who have been diagnosed with mild memory or thinking problems (mild MCI) or mild Alzheimer's disease, based on recognised international medical guidelines.
- People who have noticed a decline in their own memory and thinking for 6 months or longer.
- People whose Alzheimer's disease has been confirmed by a specialised brain scan that detects amyloid protein build-up (called an amyloid PET scan).
- People who have at least one reliable adult family member, carer, or support person who is able to attend all trial visits with them.
- People who agree to use effective birth control and have no plans to donate sperm or eggs, or to become pregnant, from the time of signing the consent form until 9 months after receiving the study drug.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a history of serious illnesses, or any current health condition that could affect the study or put them at unacceptable risk.
- People who test positive for hepatitis B, HIV, syphilis, or hepatitis C (confirm with trial site).
- People who have donated blood, experienced significant blood loss (400 mL or more in total), or received a blood transfusion in the 3 months before screening.
- People with a history of alcohol misuse in the past year, or who test positive on a breath alcohol test at screening.
- People with a history of drug or substance misuse, or who test positive on a drug screening test.
- People who have taken part in another clinical trial of a drug or medical device within the 3 months before screening.
- Women who are pregnant or breastfeeding, or women who could become pregnant and test positive on a pregnancy test.
- People whom the trial investigator considers unsuitable for the study for any other reason.
- People whose memory or thinking problems are caused by a condition other than Alzheimer's disease.
- People who have had a stroke in the 6 months before screening, or whose brain scans show significant brain disease.
- People who have had epileptic seizures or abnormal results on a brain wave test (EEG) in the 6 months before screening.
- People who have had unstable or serious health conditions in the 6 months before screening that, in the investigator's judgement, make participation unsuitable.
- People whose kidneys are not functioning well enough, based on a standard blood test result (eGFR below 60 mL/min/1.73 m²).
- People whose liver test results are significantly outside the normal range, based on specific blood test measurements (confirm with trial site for exact values).
- People who are currently taking, or are expected to need during the study, any medications that are not permitted under the study rules.
- People whom the trial investigator considers unsuitable for the study for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Contact this trial
Phone: +86-18266419923
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Not Yet Recruiting
Phase
Phase 1
Sponsor
Qilu Pharmaceutical Co., Ltd.
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 March 2027
Primary endpoints
Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 10 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.